Which of the following is MOST significant in determining a prognosis and hospice eligibility for a patient with end-stage lung disease?

Left heart failure may occur in patients with lung disease but is not a direct measure of their lung function or prognosis. While it can complicate the clinical picture, it does not directly assess the patient's ability to perform daily tasks or their overall health status in the context of end-stage lung disease.

A failed trial of beta-blockers may indicate cardiovascular issues but does not provide insight into the patient's respiratory status or general prognosis. This choice does not directly reflect the functional decline associated with lung disease, which is crucial for hospice considerations.

A pCO2 level of 35 mm Hg indicates normal carbon dioxide levels in the blood, suggesting that the patient may not be experiencing respiratory failure at that moment. However, this laboratory value alone does not sufficiently reflect the patient's overall functional status or prognosis in the context of end-stage lung disease.